<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02402621</url>
  </required_header>
  <id_info>
    <org_study_id>2015-0267</org_study_id>
    <nct_id>NCT02402621</nct_id>
  </id_info>
  <brief_title>Comparison Between Conventional and Model-based Infusion Strategy of IV PCA in Patients Undergoing RALP</brief_title>
  <official_title>Comparison Between Conventional and Model-based Infusion Strategy of Intravenous Patient-controlled Analgesia in Patients Undergoing Robot Assisted Laparoscopic Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing postoperative analgesics requirements and complications between conventional and
      model-based infusion strategy of intravenous patient-controlled analgesia in patients who
      undergoing robot assisted laparoscopic radical prostatectomy

      Group A: conventional intravenous patient-controlled analgesia, Group B: model-based infusion
      strategy of intravenous patient-controlled analgesia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators compared postoperative analgesics requirements and complications between
      conventional and model-based infusion strategy of intravenous patient-controlled analgesia
      (IV PCA) in patients who undergoing robot assisted laparoscopic radical prostatectomy (RALP)

      Group A: conventional IV PCA, Group B: model based IV PCA

        1. Primary endpoint: comparison of postoperative analgesic requirements in patient
           undergoing robot assisted laparoscopic radical prostatectomy (RALP) between conventional
           patient controlled analgesia (PCA) (Group A) and effective-compartment based dosing
           strategy of PCA (Group B)

        2. Secondary endpoint: 1) VAS analysis between two groups, 2) postoperative nausea and
           vomiting analysis between two groups, 3) complication evaluation between two groups
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount and number of postoperative analgesic requirements</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 1 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with complications</measure>
    <time_frame>Up to 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale (VAS)</measure>
    <time_frame>Up to 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>Up to 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate, oxygen saturation</measure>
    <time_frame>Up to 48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">111</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Conventional analgesic group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>fentanyl</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Model based analgesic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>fentanyl</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fentanyl</intervention_name>
    <description>fentanyl with antiemetic drug</description>
    <arm_group_label>Conventional analgesic group</arm_group_label>
    <arm_group_label>Model based analgesic group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient who is scheduled to get a robot assisted laparoscopic radical prostatectomy

          -  Patient who agree to get a patient controlled analgesia

        Exclusion Criteria:

          -  American Society of Anesthesiologist (ASA) physical status over III

          -  History of alcohol or drug addiction

          -  History of acute or chronic pain or pain treatment

          -  Allergic to opioid analgesics

          -  BMI over 30 kg/m2

          -  History of sleep apnea or respiratory complications
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young-Kug Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2015</study_first_submitted>
  <study_first_submitted_qc>March 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2015</study_first_posted>
  <last_update_submitted>November 30, 2015</last_update_submitted>
  <last_update_submitted_qc>November 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Young-Kug Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

